Bristol-Myers Squibb (BMY) Ownership - Who owns Bristol-Myers Squibb?
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BMY showed earnings on February 05, 2026. You can read more about the earnings report here.